The Chemours Company (0HWG.L)
| Previous close | 26.75 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 2,053 |
| Market cap | 44.821M |
| Beta (5Y monthly) | 2.02 |
| PE ratio (TTM) | 0.06 |
| EPS (TTM) | 4.45 |
| Earnings date | 30 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Reuters
UPDATE 1-Chemours CFO Jonathan Lock steps down after financial revisions
Chemours said on Thursday its chief financial officer, Jonathan Lock, had resigned on April 23 after the chemical firm revised certain past financial results following an internal review. Earlier this year, the internal review showed manipulation by some of its senior management to meet free cash flow targets tied to their incentives, resulting in its top three executives, including Lock and CEO Mark Newman, being placed on administrative leave. The review had identified "material weaknesses" in the company's internal control over financial reporting and resulted in revisions of its balance sheet as of Dec. 31, 2022 and its cash flow statements for 2021 and 2022.
Business WireChemours Announces Dates for First Quarter 2024 Earnings Release and Webcast Conference Call
WILMINGTON, Del., April 24, 2024--Chemours Announces Dates for First Quarter 2024 Earnings Release and Webcast Conference Call
ZacksStepan Co. (SCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Stepan Co. (SCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
